In conjunction with UCC, we recently presented the final results from a six-year analysis of Small Holder Farmers in Malawi.
Get our latest news in our recently published Newsletter Newsletter: Issue 12, October 2017
VALID Nutrition’s inspiring and innovative research is unveiled at IUNS 21st International Conference of Nutrition in Buenos Aires
The ground-breaking results from a clinical trial of a Ready-to-Use Therapeutic Food (RUTF) product made without milk or animal source protein and undertaken in Malawi in 2016, were unveiled by VALID Nutrition’s Founder, Dr Steve Collins, at the IUNS 21st International Conference on Nutrition (15th – 20th October 2017). The Soy-Maize-Sorghum (SMS) based recipe has been in development for over ten years, involving three large randomised controlled clinical trials and considerable investment from several stakeholders including Japan’s International Cooperation Agency, the Global Innovation Fund, Irish Aid and the PRANA Foundation.
Having produced 8.5 million sachets of ready-to-use therapeutic food product in 2016 (enough to treat approximately 80,000 children suffering from severe acute malnutrition) and after launching a new ready-to-use complementary food line in November 2016 to tackle chronic malnutrition, VALID Nutrition is now seeking grant funding to complement loan funding and expedite our move to a new state-of-the-art, purpose built manufacturing facility. This in turn will enable the expansion of local production capacity to meet both regional and local demand.